Birdwatch Note Rating
2023-03-15 22:00:52 UTC - NOT_HELPFUL
Rated by Participant: 33DC798C9E88FF144C627F6E368EE689117C81E2C9CC042046CA2CE6612B6315
Participant Details
Original Note:
From a GAO report on mifepristone: "FDA approved the drug under a provision of the agency’s Subpart H regulations … titled “Accelerated Approval of New Drugs". The regulation "provides FDA with flexibilities that allow the agency to accelerate the approval process" https://www.gao.gov/assets/gao-08-751.pdf
All Note Details